Daniel C. Ihde

11.4k total citations · 2 hit papers
131 papers, 8.8k citations indexed

About

Daniel C. Ihde is a scholar working on Oncology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Daniel C. Ihde has authored 131 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Oncology, 68 papers in Epidemiology and 48 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Daniel C. Ihde's work include Lung Cancer Research Studies (74 papers), Neuroendocrine Tumor Research Advances (59 papers) and Lung Cancer Treatments and Mutations (34 papers). Daniel C. Ihde is often cited by papers focused on Lung Cancer Research Studies (74 papers), Neuroendocrine Tumor Research Advances (59 papers) and Lung Cancer Treatments and Mutations (34 papers). Daniel C. Ihde collaborates with scholars based in United States, Ukraine and Canada. Daniel C. Ihde's co-authors include Paul A. Bunn, John D. Minna, Martin H. Cohen, Mary J. Matthews, Eli Glatstein, Robert Makuch, Adi F. Gazdar, Alastair J.J. Wood, Bruce E. Johnson and Robert C. Young and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Investigation.

In The Last Decade

Daniel C. Ihde

129 papers receiving 8.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Meta-Analysis of Thoracic Radiotherapy for Small-Cell Lung Cancer

1992 932 citations R. Arriagada, Daniel C. Ihde et al. New England Journal of Medicine profile →
CNS metastases in small cell bronchogenic carcinoma.Increasing frequency and changing pattern with lengthening survival

1979 361 citations Paul A. Bunn, Mary J. Matthews et al. profile →

Peers

Countries citing papers authored by Daniel C. Ihde

Since Specialization

Citations

This map shows the geographic impact of Daniel C. Ihde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel C. Ihde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel C. Ihde more than expected).

Fields of papers citing papers by Daniel C. Ihde

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel C. Ihde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel C. Ihde. The network helps show where Daniel C. Ihde may publish in the future.

Co-authorship network of co-authors of Daniel C. Ihde

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel C. Ihde. A scholar is included among the top collaborators of Daniel C. Ihde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel C. Ihde. Daniel C. Ihde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Outcome of Patients With Small-Cell Lung Cancer During 20 Years of Clinical Research at the US National Cancer Institute 1997 ·Mayo Clinic Proceedings ·John P. Chute, David Venzon, (unknown), Paul Okunieff, James N. Frame, Daniel C. Ihde, Bruce E. Johnson	24
2	Current perspectives in the treatment of small cell lung cancer: Educational symposium of the VII World Congress on Lung Cancer 1995 ·Lung Cancer ·Daniel C. Ihde	1
3	Calcitonin Elevation in Small Cell Lung Cancer Without Ectopic Production 1994 ·American Journal of Respiratory and Critical Care Medicine ·Michael J. Kelley, Kenneth L. Becker, (unknown), David Venzon, Ruby Phelps, Daniel C. Ihde, David P. Bliss, K Melby, Richard H. Snider, Bruce E. Johnson	16
4	Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer. 1994 ·Journal of Clinical Oncology ·Daniel C. Ihde, James L. Mulshine, B S Kramer, S. M. Steinberg, R. Ilona Linnoila, Adi F. Gazdar, Margaret Edison, Ruby Phelps, May Lesar, John C. Phares	194
5	Postoperative adjuvant therapy for non-small cell lung cancer: a consensus report 1994 ·Lung Cancer ·Daniel C. Ihde, David Ball, R. Arriagada, Nicole Barthélémy, Steven E. Benner, (unknown), G. Bureau, (unknown), Georges Deneffe, Bahman Emami, Ronald Feld, David Joseph, A. Paccagnella, P Rocmans, P. Van Houtte	8
6	Pretreatment minimal staging for non-small cell lung cancer: an updated consensus report 1994 ·Lung Cancer ·Peter Goldstraw, P Rocmans, David Ball, Nicole Barthélémy, James A. Bonner, M.F. Carette, Noah C. Choi, Bahman Emami, (unknown), Mark B. Hazuka, Daniel C. Ihde, Jacek Jassem, G.S. Kho, (unknown), Michel Monteau, Guy Storme, S S Wagenaar	20
7	Phase II study of pentostatin and intermittent high-dose recombinant interferon alfa-2a in advanced mycosis fungoides/Sézary syndrome. 1992 ·Journal of Clinical Oncology ·Francine M. Foss, Daniel C. Ihde, Debra Breneman, Ruby Phelps, A. B. Fischmann, GP Schechter, Ilona Linnoila, John C. Breneman, James D. Cotelingam, Bimal C. Ghosh	69
8	Small cell carcinoma of the lung: clinical and biologic aspects 1991 ·Critical Reviews in Oncology/Hematology ·Jean Viallet, Daniel C. Ihde	17
9	Outcome of patients with small-cell lung cancer: effect of changes in staging procedures and imaging technology on prognostic factors over 14 years. 1990 ·Journal of Clinical Oncology ·(unknown), S. M. Steinberg, Ruby Phelps, Mitchell J. Anderson, James L. Mulshine, Daniel C. Ihde, Bruce E. Johnson	57
10	Correlation of In Vitro Drug-Sensitivity Testing Results With Response to Chemotherapy and Survival in Extensive-Stage Small Cell Lung Cancer: A Prospective Clinical Trial 1990 ·JNCI Journal of the National Cancer Institute ·Adi F. Gazdar, Seth M. Steinberg, E K Russell, R. Ilona Linnoila, (unknown), Bidisha Ghosh, James D. Cotelingam, Bruce E. Johnson, John D. Minna, Daniel C. Ihde	78
11	Phase II trial of intermittent high-dose recombinant interferon alfa-2a in mycosis fungoides and the Sézary syndrome. 1990 ·Journal of Clinical Oncology ·Elise C. Kohn, Ronald G. Steis, E. A. Sausville, S. Veach, (unknown), Ruby Phelps, Sandra Franco, DL Longo, P A Bunn, Daniel C. Ihde	60
12	Correlation of in vitro drug sensitivity testing of long-term small cell lung cancer cell lines with response and survival 1990 ·European Journal of Cancer and Clinical Oncology ·Chun‐Ming Tsai, Daniel C. Ihde, Chikabumi Kadoyama, David Venzon, Adi F. Gazdar	17
13	A Randomized Trial Comparing Combination Electron-Beam Radiation and Chemotherapy with Topical Therapy in the Initial Treatment of Mycosis Fungoides 1989 ·New England Journal of Medicine ·Frederic J. Kaye, Paul A. Bunn, Seth M. Steinberg, (unknown), Daniel C. Ihde, A. B. Fischmann, Eli Glatstein, Geraldine P. Schechter, Ruby Phelps, Francine M. Foss, Harry L. Parlette, Michael J. Anderson, Edward A. Sausville	347
14	Treatment of localized aggressive lymphomas with combination chemotherapy followed by involved-field radiation therapy. 1989 ·Journal of Clinical Oncology ·Dan L. Longo, Eli Glatstein, P L Duffey, Daniel C. Ihde, S M Hubbard, R I Fisher, Elaine S. Jaffe, (unknown), Robert C. Young, Vincent T. DeVita	91
15	MDR1 Gene Expression in Lung Cancer 1989 ·JNCI Journal of the National Cancer Institute ·(unknown), Lori J. Goldstein, M M Gottesman, Ira Pastan, C.-M. Tsai, Bruce E. Johnson, James L. Mulshine, Daniel C. Ihde, Klaus Kayser, Adi F. Gazdar	164
16	Clinical trials in primary hepatocellular carcinoma: current status and future directions 1988 ·Cancer Treatment Reviews ·Stacy Nerenstone, Daniel C. Ihde, Michael Friedman	175
17	Residual abdominal masses in aggressive non-Hodgkin's lymphoma after combination chemotherapy: significance and management. 1988 ·Journal of Clinical Oncology ·Antonella Surbone, D L Longo, V T DeVita, Daniel C. Ihde, P L Duffey, Elaine S. Jaffe, (unknown), S M Hubbard, Robert C. Young	134
18	Experience of the National Cancer Institute (USA) in the treatment and biology of small cell lung cancer. 1982 ·PubMed ·John D. Minna, Paul A. Bunn, D. N. Carney, Martin H. Cohen, (unknown), (unknown), Adi F. Gazdar, Daniel C. Ihde, Anita Johnston-Early, Mary J. Matthews, Robert Makuch, Herbert K. Oie, Stuart D. Rosen, Allen S. Lichter, Eli Glatstein	16
19	Bleomycin, methotrexate, and streptozotocin in epidermoid carcinoma of the lung: an active drug combination with major nonhematologic toxicity. 1978 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Daniel C. Ihde, Martin H. Cohen, Paul A. Bunn, Albert M. Bernath, Lawrence E. Broder, John D. Minna	2
20	Advances in small cell bronchogenic carcinoma. 1977 ·PubMed ·Paul A. Bunn, Martin H. Cohen, Daniel C. Ihde, Byron E. Fossieck, Mary J. Matthews, John D. Minna	121

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact